In a typical day, you might eat: Breakfast: Whole-grain toast with part-skim ricotta cheese, strawberries and almonds
Key Points Summary Asias GLP1 uptake has lagged the West but is primed for rapid acceleration as obesity rates rise and government urgency grows China and India are driving demand shifts as diets westernise and metabolic disease climbs Cost barriers are falling: local firms in China and India are developing cheaper semaglutide generics, forcing price cuts Mintel forecasts explosive growth, with China potentially becoming the worlds No1 GLP1 market by 2030 Safety fears persist in China (side effects, rebound, semaglutide face) and in India (strict rules on drug promotion) GLP-1 agonist drugs have revolutionised weight loss in the United States and parts of Europe, providing in most cases a highly effective way to manage the ballooning issue of obesity in these markets
The answer isn't as simple as you might think, and getting it right is a critical, non-negotiable element of any valid research project
JACC Basic Transl Sci 2022, 7(7): 713-715
Zepbound GLP-1 Weight Loss Lose Weight Fast FDA approved Tirzepatide Targets GLP receptors to curb hunger Available as vial or injector pen Tirzepatide is a prescription medication that has been FDA-approved for weight loss since 2022